+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Insulin Delivery Devices Market (By Type - Insulin Pen, Insulin Vial & Syringes and Insulin Pumps; By Region - Europe, North America & Asia Pacific) Market Outlook 2024

  • PDF Icon


  • 124 Pages
  • November 2018
  • Region: Global
  • Rockville Research
  • ID: 4702122

The Report Provides Comprehensive Coverage on Major Industry Drivers, Restraints, and Their Impact on Market Growth During the Forecast Period

Insulin delivery devices have evolved in a big way from conventional metal syringes to intelligent insulin pens and implantable Continuous Glucose Monitoring (CGM) system for glycemic control in people with diabetes. In the year 2018, FDA approved Senseonics' Eversense continuous glucose monitoring (CGM) system, the first implantable CGM in the United States.

The report “Global Insulin Delivery Device Market - (By Type-Vials & Syringes, Insulin Pens & Insulin Pumps; By Region- North America, Europe & Asia Pacific) Market Outlook 2024” provides an in-depth analysis of global insulin as well as insulin delivery devices market across segments such as Vials & Syringes, Insulin Pens & Insulin Pumps. Market outlook for insulin delivery devices market overall as well as across various sub-segments has been provided for the period 2018-24. Regional analysis is done across major markets in North America, Europe and the Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in the global insulin delivery devices market. The report has been segmented as follows:

Market Segments

  • Vials & Syringes
  • Insulin Pens
  • Insulin Pumps

Geographical Coverage

  • North America - The US
  • Europe
  • Asia Pacific

Key Vendors

  • Novo Nordisk
  • Sanofi Aventis
  • Eli Lilly and Company
  • Merck & Co.

Products Mentioned

  • Insulin
  • Insulin delievry devices
  • Insulin pumps
  • Insulin syringes
  • Insulin pen
  • Diabetes

Table of Contents

1. Executive Summary2. Research Methodology
3. Insulin Market
3.1 Background
3.1.1 Cost - Human & Financial
3.2 Overview
3.3 Insulin Delivery Devices
3.3.1 Vials & Syringes
3.3.2 Insulin Pens
3.3.3 Insulin Pumps
4. Market Analysis
4.1 Insulin Market
4.1.1 Market Sizing (Actual & Forecasted)
4.1.2 Market Share by Insulin Type
4.1.3 Market Share by Segment
4.1.4 Market Share by Region
4.2 Insulin Delivery Devices
4.2.1 Market Sizing (Actual & Forecasted)
4.2.2 Market Share by Devices
4.2.3 Market Share by End-User
4.2.4 Market Share by Region
5. Insulin Delivery Devices - Market Segmentation
5.1 Vials and Syringes
5.1.1 Overview
5.1.2 Market Sizing (Actual & Forecasted)
5.2 Insulin Pens
5.2.1 Overview
5.2.2 Market Sizing (Actual & Forecasted)
5.2.3 Market Share by End-User
5.3 Insulin Pumps
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)
5.4 Others
6. Regional Analysis
6.1 Europe
6.1.1 Overview
6.1.2 Market Sizing (Actual & Forecasted)
6.1.3 Germany Market Sizing (Actual & Forecasted)
6.2 North America and Caribbean
6.2.1 Overview
6.2.2 Market Sizing (Actual & Forecasted)
6.2.3 The US Market Sizing (Actual & Forecasted) Market Share by Product
6.3 Asia Pacific
6.3.1 Overview
6.3.2 Market Sizing (Actual & Forecasted)
6.3.3 China Market Sizing (Actual & Forecasted)
7. Pricing Analysis
8. Global Insulin Market Dynamics
8.1 Industry Trends & Developments
8.1.1 Closed-Looped Insulin Delivery/Artificial Pancreas System
8.1.2 Implantable Continuous Glucose Monitoring (CGM) System
8.1.3 Advent of Intelligent Insulin Pens
8.1.4 Next-Generation Insulin Management System Platform
8.2 Growth Drivers
8.2.1 Increasing Incidences of Diabetes
8.2.2 Rise in Geriatric Population
8.2.3 Growing Obese Population
8.2.4 Propagation of Diabetes Management Awareness
8.2.5 Government Impetus
8.3 Challenges
8.3.1 High Cost of Insulin Pumps
8.3.2 Insurance Coverage issue
8.3.3 Regulatory Pressure
8.3.4 Technological Issue
9. Competitive Landscape
9.1 Insulin Market
9.2 Insulin Delivery Devices
9.2.1 Insulin Delivery Devices Market
9.2.2 Insulin Pens Market
9.2.3 Insulin Pumps Market
10. Company Profiles
10.1 Novo Nordisk
10.2 Sanofi Aventis
10.3 Eli Lilly and Company
10.4 Merck & Co.



Executive Summary

Insulin is a peptide hormone produced by the pancreas and is central to regulating carbohydrate and fat metabolism in the body. Insulin therapy is used for the treatment of people with type 1 diabetes in order to avoid complications arising from hyperglycemia. Insulin is administered mainly through subcutaneous insulin injections such as vials and syringes, insulin pens, and insulin pumps. In addition to this, various other physiological minimally invasive or noninvasive ways for delivering insulin are oral, buccal, nasal, peritoneal and transdermal.

Global insulin market has witnessed strong growth owing to various underlying favourable dynamics. The growth of the market is propelled by increasing incidences of diabetes, the rise in geriatric population, growing the obese population, propagation of Diabetes management awareness and government impetus. However, the market faces several challenges such as high cost of insulin pumps, insurance coverage issues, regulatory pressure and technological issues.

The report “Global Insulin Delivery Device Market - (By Type-Vials & Syringes, Insulin Pens & Insulin Pumps; By Region- North America, Europe & Asia Pacific) Market Outlook 2024” provides in-depth analysis of the current scenario, detailed market outlook of the global insulin delivery devices market with coverage on major market segments such as Vials & Syringes, Insulin Pens & Insulin Pumps. Future forecasts of insulin delivery devices market overall and across various sub-segments till 2024 is provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global insulin delivery devices market include Novo Nordisk, Sanofi Aventis, Eli Lilly and Company, Merck & Co., among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global insulin delivery devices market.

Companies Mentioned

  • Eli Lilly and Company
  • Merck & Co
  • Novo Nordisk
  • Sanofi Aventis